etrials Worldwide, the financially pressed supplier of adaptive eClinical software and services due to be acquired by fellow US company Bio-Imaging Technologies, has signed a five-year technology transfer agreement with contract research and development specialist Ockham Development Group.
The in-licensing agreement under etrials’ CRO Partnerships Solutions programme gives Ockham’s customers access to etrials’ Trial Intelligence electronic data capture (EDC) solutions. Ockham will be self-sufficient in terms of developing and deploying clinical studies with the new EDC capabilities, while etrials will provide best practices, training, hosting, development, technical, and sales and marketing support.
Ockham president Dr Joshua Baker said the addition of etrials’ adaptive solutions to the company’s own technology portfolio “increases our ability to provide an even greater breadth of integrated solutions with a highly flexible, robust EDC system delivered directly from us”.
Based like etrials near North Carolina’s Research Triangle Park, Ockham Development Group is a wholly owned subsidiary of ASG, a US company that provides functional outsourcing and speciality staffing services to contract research organisations as well as pharmaceutical, biotechnology and medical device players.
ASG acquired Ockham in February, completing a circle that saw the latter start life in 1999 as inGenium Research, a spin-off from ASG.
